Duke University School of Medicine, Durham, North Carolina.
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer. 2020 Jun 15;126(12):2859-2865. doi: 10.1002/cncr.32818. Epub 2020 Mar 25.
Investigating scientific publication trends in the field of oncology may highlight opportunities for improved representation, mentorship, collaboration, and advancement for women.
We conducted a bibliometric analysis of Annals of Surgical Oncology; Cancer; International Journal of Radiation Oncology, Biology, Physics (IJROBP); JAMA Oncology; and Journal of Clinical Oncology in 1990, 2000, 2010, and 2017. Full name and degree credentials per author role (ie, first or senior author), article type, publication year, and citation metrics were collected. First names were used to identify author gender.
Across 9189 articles, female representation rose between 1990 and 2017 (first authors: 17.7% in 1990, 36.6% in 2017; senior authors: 11.7% in 1990, 28.5% in 2017). For the 50 most cited articles per year, women comprised a smaller percent of first (26.5%) and senior (19.9%) authors. The average citation count was higher for male first (44.8 per article) and senior (47.1) authors compared to female first (39.7) and senior (44.1) authors. With male senior authors, the first author was more likely male (71.4% male; 25.0% female); with female senior authors, first authors were 50.2% male and 47.6% female. IJROBP had the lowest total female representation among first (25.1%) and senior (16.7%) authors. Women had more MDs with Masters degrees, whereas men held more MDs only and more MDs with PhDs.
Despite positive trends, substantial gendered differences in oncology publications persist. Fostering more women in oncology research will benefit female representation at many levels of academia and improve productivity, collaboration, and recruitment, especially in technical fields such as radiation and surgical oncology.
研究肿瘤学领域的科学出版趋势，可以突出为女性提供更好的代表性、指导、合作和晋升机会。
我们对《外科肿瘤学年鉴》、《癌症》、《国际肿瘤放射生物学与物理学杂志》（IJROBP）、《JAMA 肿瘤学》和《临床肿瘤学杂志》在 1990 年、2000 年、2010 年和 2017 年的文献进行了计量分析。按作者角色（即第一作者或资深作者）、文章类型、出版年份和引文指标收集每位作者的全名和学位证书。使用名字来识别作者的性别。
在 9189 篇文章中，女性代表比例从 1990 年上升到 2017 年（第一作者：1990 年 17.7%，2017 年 36.6%；资深作者：1990 年 11.7%，2017 年 28.5%）。在每年最具影响力的 50 篇文章中，女性第一作者（26.5%）和资深作者（19.9%）的比例较小。与女性第一作者（39.7）和资深作者（44.1）相比，男性第一作者（44.8 篇）和资深作者（47.1）的平均引文数更高。男性资深作者的第一作者更可能是男性（71.4%是男性，25.0%是女性）；而女性资深作者的第一作者 50.2%是男性，47.6%是女性。IJROBP 的第一作者（25.1%）和资深作者（16.7%）中女性的总数比例最低。女性拥有更多的医学博士和硕士学位，而男性则拥有更多的医学博士学位和更少的博士学位。
尽管呈积极趋势，但肿瘤学出版物中仍然存在明显的性别差异。促进更多女性参与肿瘤学研究将在学术界的许多层面上受益于女性的代表性，并提高生产力、合作和招聘，特别是在放射和外科肿瘤学等技术领域。
